vs
GE医疗（CCRN）与ENTRAVISION COMMUNICATIONS CORP（EVC）财务数据对比。点击上方公司名可切换其他公司
GE医疗的季度营收约是ENTRAVISION COMMUNICATIONS CORP的1.8倍（$236.8M vs $134.4M），ENTRAVISION COMMUNICATIONS CORP净利率更高（-13.5% vs -35.0%，领先21.5%），ENTRAVISION COMMUNICATIONS CORP同比增速更快（25.6% vs -23.6%），GE医疗自由现金流更多（$16.1M vs $8.7M），过去两年ENTRAVISION COMMUNICATIONS CORP的营收复合增速更高（31.1% vs -21.0%）
GE医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，品牌标识为GE HealthCare。公司主要业务分为四大板块：包含分子影像、CT、磁共振、妇科筛查及X光设备的医学影像业务、超声业务，以及聚焦远程患者监测、麻醉呼吸护理、心脏诊断、婴幼儿护理的患者护理解决方案业务，此外还开展医药相关业务。
恩特拉维申通讯是一家总部位于加利福尼亚州圣塔莫尼卡的美国媒体企业，核心受众为西班牙语裔拉美社群，在多个主要拉美受众市场拥有电视台、广播电台及户外媒体资产，是Univision和UniMás电视网最大的加盟集团，同时也拥有少量英语广播电视资源。
CCRN vs EVC — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $236.8M | $134.4M |
| 净利润 | $-82.9M | $-18.2M |
| 毛利率 | — | 54.1% |
| 营业利润率 | -30.2% | -15.4% |
| 净利率 | -35.0% | -13.5% |
| 营收同比 | -23.6% | 25.6% |
| 净利润同比 | -2109.7% | 67.7% |
| 每股收益（稀释后） | $-2.56 | $-0.19 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $236.8M | $134.4M | ||
| Q3 25 | $250.1M | $120.6M | ||
| Q2 25 | $274.1M | $100.7M | ||
| Q1 25 | $293.4M | $91.9M | ||
| Q4 24 | $309.9M | $107.0M | ||
| Q3 24 | $315.1M | $97.2M | ||
| Q2 24 | $339.8M | $82.7M | ||
| Q1 24 | $379.2M | $78.2M |
| Q4 25 | $-82.9M | $-18.2M | ||
| Q3 25 | $-4.8M | $-9.7M | ||
| Q2 25 | $-6.7M | $-3.3M | ||
| Q1 25 | $-490.0K | $-48.0M | ||
| Q4 24 | $-3.8M | $-56.4M | ||
| Q3 24 | $2.6M | $-12.0M | ||
| Q2 24 | $-16.1M | $-31.7M | ||
| Q1 24 | $2.7M | $-48.9M |
| Q4 25 | — | 54.1% | ||
| Q3 25 | 20.4% | 57.7% | ||
| Q2 25 | 20.4% | 62.3% | ||
| Q1 25 | 20.0% | 63.6% | ||
| Q4 24 | — | 73.5% | ||
| Q3 24 | 20.4% | 72.4% | ||
| Q2 24 | 20.8% | 70.5% | ||
| Q1 24 | 20.4% | 71.0% |
| Q4 25 | -30.2% | -15.4% | ||
| Q3 25 | -2.4% | -7.5% | ||
| Q2 25 | -2.1% | -0.8% | ||
| Q1 25 | -0.3% | -57.5% | ||
| Q4 24 | -1.1% | -45.4% | ||
| Q3 24 | 0.9% | 7.8% | ||
| Q2 24 | -5.7% | -4.0% | ||
| Q1 24 | 0.8% | -9.8% |
| Q4 25 | -35.0% | -13.5% | ||
| Q3 25 | -1.9% | -8.0% | ||
| Q2 25 | -2.4% | -3.3% | ||
| Q1 25 | -0.2% | -52.2% | ||
| Q4 24 | -1.2% | -52.7% | ||
| Q3 24 | 0.8% | -12.3% | ||
| Q2 24 | -4.7% | -38.3% | ||
| Q1 24 | 0.7% | -62.5% |
| Q4 25 | $-2.56 | $-0.19 | ||
| Q3 25 | $-0.15 | $-0.11 | ||
| Q2 25 | $-0.20 | $-0.04 | ||
| Q1 25 | $-0.02 | $-0.53 | ||
| Q4 24 | $-0.13 | $-0.63 | ||
| Q3 24 | $0.08 | $-0.13 | ||
| Q2 24 | $-0.47 | $-0.35 | ||
| Q1 24 | $0.08 | $-0.55 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $108.7M | $63.2M |
| 总债务越低越好 | — | $167.7M |
| 股东权益账面价值 | $322.8M | $55.4M |
| 总资产 | $449.0M | $387.5M |
| 负债/权益比越低杠杆越低 | — | 3.02× |
8季度趋势，按日历期对齐
| Q4 25 | $108.7M | $63.2M | ||
| Q3 25 | $99.1M | $66.4M | ||
| Q2 25 | $81.2M | $69.3M | ||
| Q1 25 | $80.7M | $78.1M | ||
| Q4 24 | $81.6M | $100.6M | ||
| Q3 24 | $64.0M | $93.1M | ||
| Q2 24 | $69.6M | $88.3M | ||
| Q1 24 | $5.2M | $102.8M |
| Q4 25 | — | $167.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $187.8M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $322.8M | $55.4M | ||
| Q3 25 | $408.1M | $78.2M | ||
| Q2 25 | $412.2M | $90.0M | ||
| Q1 25 | $418.2M | $95.6M | ||
| Q4 24 | $419.0M | $146.0M | ||
| Q3 24 | $424.7M | $207.4M | ||
| Q2 24 | $433.3M | $220.4M | ||
| Q1 24 | $462.4M | $173.5M |
| Q4 25 | $449.0M | $387.5M | ||
| Q3 25 | $538.2M | $414.6M | ||
| Q2 25 | $553.8M | $418.0M | ||
| Q1 25 | $576.2M | $435.8M | ||
| Q4 24 | $589.3M | $487.3M | ||
| Q3 24 | $597.4M | $557.3M | ||
| Q2 24 | $602.9M | $569.6M | ||
| Q1 24 | $648.4M | $805.0M |
| Q4 25 | — | 3.02× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.29× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.2M | $9.8M |
| 自由现金流经营现金流 - 资本支出 | $16.1M | $8.7M |
| 自由现金流率自由现金流/营收 | 6.8% | 6.5% |
| 资本支出强度资本支出/营收 | 0.9% | 0.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $40.1M | $3.5M |
8季度趋势，按日历期对齐
| Q4 25 | $18.2M | $9.8M | ||
| Q3 25 | $20.1M | $8.3M | ||
| Q2 25 | $4.2M | $7.8M | ||
| Q1 25 | $5.7M | $-15.2M | ||
| Q4 24 | $24.2M | $12.8M | ||
| Q3 24 | $7.5M | $10.9M | ||
| Q2 24 | $82.4M | $17.7M | ||
| Q1 24 | $6.0M | $33.4M |
| Q4 25 | $16.1M | $8.7M | ||
| Q3 25 | $17.9M | $7.1M | ||
| Q2 25 | $2.3M | $5.7M | ||
| Q1 25 | $3.8M | $-17.9M | ||
| Q4 24 | $21.7M | $10.6M | ||
| Q3 24 | $6.3M | $9.3M | ||
| Q2 24 | $79.6M | $15.7M | ||
| Q1 24 | $3.8M | $30.6M |
| Q4 25 | 6.8% | 6.5% | ||
| Q3 25 | 7.2% | 5.9% | ||
| Q2 25 | 0.8% | 5.6% | ||
| Q1 25 | 1.3% | -19.5% | ||
| Q4 24 | 7.0% | 9.9% | ||
| Q3 24 | 2.0% | 9.6% | ||
| Q2 24 | 23.4% | 19.0% | ||
| Q1 24 | 1.0% | 39.2% |
| Q4 25 | 0.9% | 0.8% | ||
| Q3 25 | 0.9% | 1.0% | ||
| Q2 25 | 0.7% | 2.1% | ||
| Q1 25 | 0.6% | 2.9% | ||
| Q4 24 | 0.8% | 2.0% | ||
| Q3 24 | 0.4% | 1.6% | ||
| Q2 24 | 0.8% | 2.4% | ||
| Q1 24 | 0.6% | 3.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.92× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.23× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
EVC
| Digital Advertising | $98.1M | 73% |
| Broadcast Advertising | $27.4M | 20% |
| Retransmission Consent | $6.3M | 5% |
| Other Product Or Services | $1.3M | 1% |
